BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Diagnosis
4 results:

  • 1. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
    Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
    Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR.
    Wang H; Yang B; Geng T; Li B; Dai P; Chen C
    Exp Mol Pathol; 2015 Jun; 98(3):375-81. PubMed ID: 25445497
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.
    Barth BM; Sharma R; Altinoğlu EI; Morgan TT; Shanmugavelandy SS; Kaiser JM; McGovern C; Matters GL; Smith JP; Kester M; Adair JH
    ACS Nano; 2010 Mar; 4(3):1279-87. PubMed ID: 20180585
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells.
    Osma MM; Ortuño F; Lozano ML; Gomez-Espuch J; Ayala F; Sanchez-Serrano I; Perez-Ceballos E; Moraleda JM; Vicente V
    Bone Marrow Transplant; 2001 Jun; 27(12):1287-92. PubMed ID: 11548847
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.